Design, synthesis and biological evaluation of alkynyl-containing maleimide derivatives for the treatment of drug-resistant tuberculosis.

[1]  G. Besra,et al.  Discovery of Novel Thiophene-arylamide Derivatives as DprE1 Inhibitors with Potent Antimycobacterial Activities , 2021, Journal of medicinal chemistry.

[2]  M. D. De Rosa,et al.  Tuberculosis: An Overview of the Immunogenic Response, Disease Progression, and Medicinal Chemistry Efforts in the Last Decade toward the Development of Potential Drugs for Extensively Drug-Resistant Tuberculosis Strains. , 2021, Journal of medicinal chemistry.

[3]  V. Tiwari,et al.  Tuberculosis: An Update on Pathophysiology, Molecular Mechanisms of Drug Resistance, Newer Anti-TB Drugs, Treatment Regimens and Host-Di-rected Therapies. , 2020, Current topics in medicinal chemistry.

[4]  E. Jaramillo,et al.  World Health Organization recommendations on the treatment of drug-resistant tuberculosis, 2020 update , 2020, European Respiratory Journal.

[5]  R. Bonomo,et al.  Drug-Resistant Tuberculosis: A Glance at Progress and Global Challenges. , 2020, Infectious disease clinics of North America.

[6]  Akshay Dhayagude,et al.  Novel Schiff bases derived from N-aryl maleimide derivatives as an effective antimicrobial agent: Theoretical and experimental approach. , 2020, Bioorganic chemistry.

[7]  P. Li,et al.  Design, synthesis and biological evaluation of diamino substituted cyclobut-3-ene-1,2-dione derivatives for the treatment of drug-resistant tuberculosis. , 2020, European journal of medicinal chemistry.

[8]  Phyo Phyo Kyaw Zin,et al.  Molecule Property Analyses of Active Compounds for Mycobacterium Tuberculosis. , 2020, Journal of medicinal chemistry.

[9]  G. Ippolito,et al.  Cover Editorial- IJID World TB Day 2020 Theme Series. , 2020, International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases.

[10]  A. Garcia-Basteiro,et al.  MDR/XDR-TB management of patients and contacts: challenges facing the new decade. The 2020 clinical update by the Global Tuberculosis Network. , 2020, International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases.

[11]  G. Besra,et al.  Identification of novel benzothiopyranone compounds against Mycobacterium tuberculosis through scaffold morphing from benzothiazinones. , 2018, European journal of medicinal chemistry.

[12]  Pedro M. P. Gois,et al.  Bioconjugation with Maleimides: A Useful Tool for Chemical Biology. , 2018, Chemistry.

[13]  Shiyuan Sun,et al.  Unexpected [2+2] Photocycloaddition between Enediyne Compounds in Solid State , 2017 .

[14]  P. Lu,et al.  Targeting Energy Metabolism in Mycobacterium tuberculosis, a New Paradigm in Antimycobacterial Drug Discovery , 2017, mBio.

[15]  Christopher B. Cooper,et al.  Discovery of Imidazo[1,2-a]pyridine Ethers and Squaramides as Selective and Potent Inhibitors of Mycobacterial Adenosine Triphosphate (ATP) Synthesis. , 2017, Journal of medicinal chemistry.

[16]  K. Floyd,et al.  Twenty Years of Global Surveillance of Antituberculosis-Drug Resistance. , 2016, The New England journal of medicine.

[17]  Samsher Singh,et al.  Ligand Free Palladium Catalyzed Synthesis of 3-Aryl/heteroaryl-4-Indolylmaleimide and its Antimicrobial Activity. , 2016 .

[18]  G. Bérubé,et al.  Identification of an anti-inflammatory derivative with anti-cancer potential: The impact of each of its structural components on inflammatory responses in macrophages and bladder cancer cells. , 2015, European journal of medicinal chemistry.

[19]  L. Eckhardt-Strelau,et al.  Structure of the mycobacterial ATP synthase Fo rotor ring in complex with the anti-TB drug bedaquiline , 2015, Science Advances.

[20]  P. Lu,et al.  ATP synthase in mycobacteria: special features and implications for a function as drug target. , 2014, Biochimica et biophysica acta.

[21]  T. Buclin,et al.  Towards a new combination therapy for tuberculosis with next generation benzothiazinones , 2014, EMBO molecular medicine.

[22]  R. Enriz,et al.  Antifungal, cytotoxic and SAR studies of a series of N-alkyl, N-aryl and N-alkylphenyl-1,4-pyrrolediones and related compounds. , 2011, Bioorganic & medicinal chemistry.

[23]  Gavin Churchyard,et al.  The diarylquinoline TMC207 for multidrug-resistant tuberculosis. , 2009, The New England journal of medicine.

[24]  T. Bansode,et al.  Synthesis and antimicrobial activity of some new N-acyl substituted phenothiazines. , 2009, European journal of medicinal chemistry.

[25]  Anish Kumar,et al.  Fullerene Isoniazid Conjugate – A Tuberculostat with Increased Lipophilicity: Synthesis and Evaluation of Antimycobacterial Activity , 2009, Chemical Biology and Drug Design.

[26]  A. Kozikowski,et al.  From a natural product lead to the identification of potent and selective benzofuran-3-yl-(indol-3-yl)maleimides as glycogen synthase kinase 3beta inhibitors that suppress proliferation and survival of pancreatic cancer cells. , 2009, Journal of medicinal chemistry.

[27]  Hinrich W. H. Göhlmann,et al.  A Diarylquinoline Drug Active on the ATP Synthase of Mycobacterium tuberculosis , 2005, Science.

[28]  P. Lambert,et al.  Cellular impermeability and uptake of biocides and antibiotics in Gram‐positive bacteria and mycobacteria , 2002, Symposium series.

[29]  G. Cook,et al.  Targeting bacterial energetics to produce new antimicrobials. , 2018, Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy.

[30]  Qiaojun He,et al.  Synthesis and Antitumor Activity of Novel 4-Chloro-3-Arylmaleimide Derivatives , 2009 .